| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |